Top

Published in:

01-03-2020 | Ankylosing Spondylitis | Correspondence

Comment on “Effects of 1-year anti-TNF-α therapy on vascular function in rheumatoid arthritis and ankylosing spondylitis”

Published in: Rheumatology International | Issue 3/2020

Excerpt

Dear Editor, …

Végh E, Kerekes G, Pusztai A et al (2019) Effects of 1-year anti-TNF-α therapy on vascular function in rheumatoid arthritis and ankylosing spondylitis. Rheumatol Int 1:4. https://doi.org/10.1007/s00296-019-04497-0 CrossRef

Cure E, Icli A, Uslu AU et al (2018) Atherogenic index of plasma: a useful marker for subclinical atherosclerosis in ankylosing spondylitis: AIP associate with cIMT in AS. Clin Rheumatol 37:1273–1280. https://doi.org/10.1007/s10067-018-4027-0 CrossRefPubMed

Turkyilmaz AK, Devrimsel G, Kirbas A, Cicek Y, Karkucak M, Capkin E, Gokmen F (2013) Relationship between pulse wave velocity and serum YKL-40 level in patients with early rheumatoid arthritis. Rheumatol Int 33:2751–2756. https://doi.org/10.1007/s00296-013-2810-4 CrossRefPubMed

Cure E, Icli A, Ugur Uslu A et al (2017) Atherogenic index of plasma may be strong predictor of subclinical atherosclerosis in patients with Behçet disease. Z Rheumatol 76:259–266. https://doi.org/10.1007/s00393-016-0141-z CrossRefPubMed

Herder M, Johnsen SH, Arntzen KA et al (2012) Risk factors for progression of carotid intima-media thickness and total plaque area: a 13-year follow-up study: the Tromsø Study. Stroke 43:1818–1823. https://doi.org/10.1161/STROKEAHA.111.646596 CrossRefPubMed

Rosvall M, Persson M, Östling G et al (2015) Risk factors for the progression of carotid intima-media thickness over a 16-year follow-up period: the Malmö Diet and Cancer Study. Atherosclerosis 239:615–621. https://doi.org/10.1016/j.atherosclerosis.2015.01.030 CrossRefPubMed

Lorenz MW, Price JF, Robertson C et al (2015) Carotid intima-media thickness progression and risk of vascular events in people with diabetes: results from the PROG-IMT collaboration. Diabetes Care 38:1921–1929. https://doi.org/10.2337/dc14-2732 CrossRefPubMedPubMedCentral

Stanek A, Cholewka A, Wielkoszyński T, Romuk E, Sieron K, Sieron A (2017) Increased levels of oxidative stress markers, soluble CD40 ligand, and carotid intima-media thickness reflect acceleration of atherosclerosis in male patients with ankylosing spondylitis in active phase and without the classical cardiovascular risk factors. Oxid Med Cell Longev 2017:9712536. https://doi.org/10.1155/2017/9712536 CrossRefPubMedPubMedCentral

Biskup M, Biskup W, Majdan M, Targonska-Stępniak B (2018) Cardiovascular system changes in rheumatoid arthritis patients with continued low disease activity. Rheumatol Int 38:1207–1215. https://doi.org/10.1007/s00296-018-4053-x CrossRefPubMedPubMedCentral

10.

Zardi EM, Pipita ME, Giorgi C, Lichinchi D, Zardi DM, Afeltra A (2018) Differences in carotid atherosclerosis between patients with ankylosing spondylitis treated with tumor necrosis factor-α antagonists and healthy matched controls. Medicine (Baltimore) 97:e11250. https://doi.org/10.1097/MD.0000000000011250 CrossRef

Title: Comment on “Effects of 1-year anti-TNF-α therapy on vascular function in rheumatoid arthritis and ankylosing spondylitis”
Publication date: 01-03-2020
Keywords: Ankylosing Spondylitis
Rheumatoid Arthritis
Published in: Rheumatology International / Issue 3/2020
Print ISSN: 0172-8172
Electronic ISSN: 1437-160X
DOI: https://doi.org/10.1007/s00296-020-04513-8

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Comment on “Effects of 1-year anti-TNF-α therapy on vascular function in rheumatoid arthritis and ankylosing spondylitis”

Excerpt

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 3/2020

All-cause hospitalizations and mortality in systemic lupus erythematosus in the US: results from a national inpatient database

Physical activity and sedentary behaviour and their associations with clinical measures in axial spondyloarthritis

The effects of exercise on cardiovascular disease risk factors and cardiovascular physiology in rheumatoid arthritis

Prevalence of high-sensitivity cardiac troponin T in real-life cohorts of psoriatic arthritis and general population: a cross-sectional study

Tobacco smoking is an independent factor associated with retinal damage in systemic lupus erythematosus: a cross-sectional and retrospective study

Comparison of physical activity among different subsets of patients with knee or hip osteoarthritis and the general population

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page